Linaclotide-containing formulations for oral administration

Details for Australian Patent Application No. 2009282446 (hide)

Owner Forest Laboratories Holdings Limited Ironwood Pharmaceuticals, Inc.

Inventors Fretzen, Angelika; Witowski, Steven; Grossi, Alfredo; Zhao, Hong; Dedhiya, Mahendra; Mo, Yun

Agent Spruson & Ferguson

Pub. Number AU-A-2009282446

PCT Pub. Number WO2010/019266

Priority 61/089,422 15.08.08 US; 61/273,332 03.08.09 US; 61/231,725 06.08.09 US

Filing date 14 August 2009

Wipo publication date 18 February 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

24 March 2011 PCT application entered the National Phase

  PCT publication WO2010/019266 Priority application(s): WO2010/019266

16 June 2011 Assignment before Grant

  Forest Laboratories Holdings Limited; Ironwood Pharmaceuticals, Inc. The application has been assigned to Ironwood Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282451-Fluorescent regulators of RASSF1A expression and human cancer cell proliferation

2009282442-Polyvalent vaccine